Dietary Fiber Health Claim Regulation: A Formulator’s Guide to FDA, EFSA, and Global Compliance

How the EU and EFSA Regulate Fiber Claims

In the European Union, EFSA dietary fiber health claims operate under the EU Nutrition and Health Claims Regulation fiber framework — formally Regulation (EC) No 1924/2006. Every claim, whether on a label, a spec sheet, or a company website, must appear on the EU Register of authorised claims before it can be used commercially.

Content claims come first: a product can be labeled a “source of fiber” if it contains at least 3 g of fiber per 100 g (or 1.5 g per 100 kcal), while “high in fiber” requires at least 6 g per 100 g (or 3 g per 100 kcal). This EFSA “source of fiber” vs “high in fiber” claim distinction is one of the most common fiber nutrient content claim requirements formulators run into during EU dossier prep, and it applies before any health claim can even be considered.

Health claims themselves are stricter still. EFSA’s 2010 scientific opinion found insufficient evidence to authorize a general claim for “dietary fiber” as a category, but it has separately authorized specific claims for individual fibers — barley grain fiber and oat fiber contributing to increased faecal bulk, and beta-glucans supporting normal blood cholesterol levels, among others.

This is a useful pattern to remember: the EU doesn’t reward broad, feel-good fiber language. It rewards specificity. A claim tied to a named fiber source, a defined intake level, and a registered health relationship will clear review; a generic “fiber is good for you” statement, however true, simply isn’t a claim EFSA has authorized for use.

Codex Alimentarius: The Global Baseline for Defining Fiber

Codex Alimentarius dietary fiber definition work, set out in the Codex Guidelines on Nutrition Labelling (CAC/GL 2-1985, revised over subsequent sessions), underpins how many national regulators — including the EU — define fiber for labeling purposes. Codex defines dietary fiber as carbohydrate polymers with ten or more monomeric units that resist digestion in the small intestine, while leaving the decision on shorter-chain carbohydrates (three to nine units) to individual national authorities.

That flexibility explains why FDA, EFSA, and other agencies don’t always agree on which specific ingredients qualify. A fiber source approved in one market may need additional data — or simply won’t qualify — in another, which is precisely why market-entry planning for fiber-forward products should start with the applicable regulatory definition, not just the intended health claim.

This is also why Codex functions less like a single rulebook and more like a shared reference point. Countries building or updating their own food labeling systems tend to anchor their definitions to it, then layer on national health-claim requirements. For a supplier or brand shipping into multiple regions at once, that shared foundation is genuinely helpful — it means the underlying fiber definition rarely needs to be re-argued from scratch in each new market, even when the claim process itself differs.

Japan’s FOSHU System and Fiber Claims Across Asia-Pacific

Japan takes a fundamentally different approach. Rather than one overarching claims regulation, Japan’s Ministry of Health, Labour and Welfare oversees Foods for Specified Health Uses (FOSHU) — a pre-market approval system dating to 1991 that requires clinical evidence and government review before a product can carry a specific health statement.

A FOSHU fiber health claim Japan approval typically covers gut-related functions: indigestible dextrin, polydextrose, guar gum, and psyllium seed coat are among the principal fiber ingredients recognized for foods that modify gastrointestinal conditions. Since 2015, a lighter-touch alternative — Foods with Function Claims — has also let companies self-notify claims backed by scientific evidence without full FOSHU pre-approval, giving formulators targeting the Japanese market two distinct compliance paths depending on timeline and risk tolerance.

Not All Fibers Are Equal: Ingredient-Specific Claim Considerations

Because regulators evaluate fiber sources individually, the practical question for most B2B buyers isn’t “is fiber good for you” — it’s “does this specific ingredient qualify for the claim I want to make.” A resistant dextrin health claim, for example, depends on whether the ingredient meets FDA’s added-fiber criteria; resistant maltodextrin/dextrin was one of eight non-digestible carbohydrates FDA recognized as meeting its dietary fiber definition through 2018 guidance, following citizen petitions built on postprandial blood glucose and triglyceride response data. Is resistant dextrin considered dietary fiber by FDA? Yes — but only when it’s sourced and documented to match the recognized ingredient profile.

Other ingredients follow the same pattern. A beta-glucan soluble fiber heart disease claim requires meeting the specific intake thresholds in 21 CFR 101.81, and a psyllium husk FDA health claim carries its own separate minimum soluble fiber requirement. Meanwhile, prebiotic fiber claim regulation is still evolving — most prebiotic and gut-microbiome statements fall under structure/function or qualified claims rather than authorized ones — and a fiber and blood glucose health claim or fiber and cholesterol reduction claim each demands its own body of clinical substantiation. The takeaway for formulators: choose the ingredient based on the claim you need, not the other way around.

This ingredient-by-ingredient reality also shapes formulation categories that don’t look like obvious “fiber products” on the surface — fortified cereals, high-protein dairy, prebiotic beverages, and meal replacements among them. In each case, the fiber source has to satisfy both the technical formulation requirements (solubility, viscosity, heat stability) and the regulatory requirements for whatever claim sits on the front of pack, which is why claim strategy and ingredient selection really have to happen in the same conversation, not sequentially.